Milder Donald B
SEC-identified person · CIK 1279660 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Inari Medical, Inc. NARI | Director | filed 2020–2025 |
| Flexion Therapeutics Inc FLXN | Director | filed 2014–2016 |
| Glaukos Corp GKOS | Officer | filed 2015–2016 |
| Phaserx, INC. PZRX | Officer | filed 2016–2016 |
| Inogen Inc INGN | Officer | filed 2014–2015 |
| Vivani Medical, Inc. VANI | Officer | filed 2014–2014 |
| Helicos Biosciences Corp HLCS | Officer | filed 2007–2009 |
| Insulet Corp PODD | Officer | filed 2007–2007 |
| Transcept Pharmaceuticals Inc TSPT | Officer | filed 2006–2006 |
| Alexza Pharmaceuticals Inc. ALXA | Officer | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.